Condition: Stroke · Chronic Stroke Patients · Cerebrovascular Accident (CVA) · Sponsor: University of Florida
This trial tests a promising new intervention to promote post-stroke neural reorganization and functional recovery. The Q Therapeutic (BQ 3.0) is a wearable medical system that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. This trial is a prospective, single-arm, open-label, single center clinical trial designed to evaluate the safety, feasibility, and efficacy of the Q Therapeutic (BQ 3.0) System in the rehabilitation of people with chronic stroke.
This description comes directly from the study's public registry record.
Emily J Fox, PT, DPT, MHS, PhD · 904-742-2500 · ejfox@phhp.ufl.edu
Jennifer Brooke Hoisington, MSPT · 904-659-3733 · brooke.hoisington@brooksrehab.org
Always discuss trial participation with your own doctor first.
| Brooks Rehabilitation Clinical Research Center | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07095920